Blog
0
Poor Liver Function Can Cause Side Effects, Drug Discontinuation in HCC
0

Researchers have found that among patients with hepatocellular carcinoma (the most common liver cancer) that is unresectable (cannot be removed by surgery) ...

0
Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC
0

Patients with resectable mismatch repair–proficient and mismatch repair–deficient colorectal cancer treated with neoadjuvant (treatment given to shrink a ...

0
Clogged Plumbing: Constipation and Cancer Treatment
0

Some side effects of cancer treatment are difficult to talk about. Constipation is high on that list. My teenage daughter always laughs whenever she hears ...

0
Tecentriq-Tiragolumab-Chemo Combo Showed Improved Survival in ESCC
0

Adding Tecentriq and tiragolumab to chemotherapy improved outcomes in patients with a certain type of esophageal cancer. Patients with esophageal squamous ...

0
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
0

It wasn’t even two weeks into the new year when the Food and Drug Administration made their first FDA approval. In this case, it was a Keytruda regimen for ...

0
Why the Government needs to do more to attract international researchers – Cancer Research UK
0

In the face of these difficulties, the government has highlighted the Global Talent Visa (GTV) as the key to attracting and retaining international ...

0
6 articles to clue you up on cervical cancer prevention
0

2. Understanding HPV in screening  Cervical screening is one of 3 cancer screening programmes in the UK. It is offered to most women, some trans men and ...

0
Vitrakvi Continues to Improve Survival, Safety in TRK Fusion GI Cancers
0

In patients with TRK fusion gastrointestinal cancers, treatment with Vitrakvi (larotrectinib) continued to demonstrate long-lasting responses, longer ...

0
Normalcy Following a Life-Threatening Cancer Diagnosis
0

On January 2, 2020, my oncologist, Dr. G, told me I was in remission from stage 3B lung cancer.My husband and I stopped at Dunkin Donuts on the way home to ...

0
Frontline Keytruda, Lenvima Betters Duration of Response in Advanced Liver Cancer
0

Adding Keytruda (pembrolizumab) to Lenvima (lenvatinib) led to better duration of response outcomes than Lenvima plus placebo in patients with advanced ...

0
Avastin Plus Chemo for Metastatic Colorectal Cancer Increases Over Time
0

The rate of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI plus Avastin (bevacizumab) has increased over time, ...

0
3-Drug Regimen May Be Underutilized in Metastatic CRC
0

The use of FOLFOXIRI (a chemotherapy triplet), with or without Avastin (bevacizumab) to treat metastatic colorectal cancer has been increasing in recent ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart